Found 75 results
Author [ Keyword(Asc)] Title Type Year
Filters: Author is Muchiri, Ruth N  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Virus Internalization
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
Vero Cells
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
Vascular Endothelial Growth Factor A
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.
Tandem Mass Spectrometry
Muchiri RN, Kowal KE, Hensley K, Feinstein DL, van Breemen RB.  2018.  Analysis of lanthionine ketimine ethyl ester in mouse serum, whole blood and tissues using ultrahigh-pressure liquid chromatography/tandem mass spectrometry.. Rapid Commun Mass Spectrom. 32(22):1941-1948.
Spike Glycoprotein, Coronavirus
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
Sorafenib
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.
Sheep
Irawan A, Muchiri RN, Parker NB, van Breemen RB, Ates S, Bionaz M.  2024.  Cannabinoid residuals in tissues of lambs fed spent hemp biomass and consumer's exposure assessment.. Food Chem Toxicol. 191:114848.
SARS-CoV-2
van Breemen RB, Muchiri RN.  2024.  Affinity selection-mass spectrometry in the discovery of anti-SARS-CoV-2 compounds.. Mass Spectrom Rev. 43(1):39-46.
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
Rabbits
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.
Protein Binding
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
Pandemics
van Breemen RB, Muchiri RN.  2024.  Affinity selection-mass spectrometry in the discovery of anti-SARS-CoV-2 compounds.. Mass Spectrom Rev. 43(1):39-46.
Necrosis
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.
Molecular Docking Simulation
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
Models, Molecular
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
Mice
Muchiri RN, Kowal KE, Hensley K, Feinstein DL, van Breemen RB.  2018.  Analysis of lanthionine ketimine ethyl ester in mouse serum, whole blood and tissues using ultrahigh-pressure liquid chromatography/tandem mass spectrometry.. Rapid Commun Mass Spectrom. 32(22):1941-1948.
Mass Spectrometry
Muchiri RN, van Breemen RB.  2021.  Drug discovery from natural products using affinity selection-mass spectrometry.. Drug Discov Today Technol. 40:59-63.
van Breemen RB, Muchiri RN, Bates TA, Weinstein JB, Leier HC, Farley S, Tafesse FG.  2022.  Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants.. J Nat Prod. 85(1):176-184.
van Breemen RB, Muchiri RN.  2024.  Affinity selection-mass spectrometry in the discovery of anti-SARS-CoV-2 compounds.. Mass Spectrom Rev. 43(1):39-46.
Muchiri RN, Kibitel J, Redick MA, van Breemen RB.  2022.  Advances in Magnetic Microbead Affinity Selection Screening: Discovery of Natural Ligands to the SARS-CoV-2 Spike Protein.. J Am Soc Mass Spectrom. 33(1):181-188.
Liver Neoplasms
Elkhadragy L, Khabbaz RC, Muchiri RN, Totura WM, Samuelson JP, Whiteley HE, van Breemen RB, R Lokken P, Gaba RC.  2022.  Pharmacokinetics and Early Tumor Response to Conventional Transarterial Chemoembolization with Sorafenib and Doxorubicin in a VX2 Rabbit Tumor Model.. J Vasc Interv Radiol. 33(10):1213-1221.e5.
Liver
Irawan A, Muchiri RN, Parker NB, van Breemen RB, Ates S, Bionaz M.  2024.  Cannabinoid residuals in tissues of lambs fed spent hemp biomass and consumer's exposure assessment.. Food Chem Toxicol. 191:114848.

Pages